Literature DB >> 21851994

Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care.

Per E Wändell, Axel C Carlsson, Kristina Sundquist, Sven-Erik Johansson, Jan Sundquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21851994     DOI： 10.1016/j.ijcard.2011.07.066

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

1.  Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiol       Date:  2017-08-30       Impact factor: 2.778

2.  Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.

Authors:  Per Wändell; Axel C Carlsson; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-09-19       Impact factor: 2.953

3.  Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-06-10       Impact factor: 2.953

4.  Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.

Authors:  Axel C Carlsson; Per Wändell; Danijela Gasevic; Jan Sundquist; Kristina Sundquist
Journal:  Int J Cardiol       Date:  2015-04-01       Impact factor: 4.164

5.  Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Sven-Erik Johansson; Matteo Bottai; Kristina Sundquist
Journal:  Diabetol Metab Syndr       Date:  2014-01-07       Impact factor: 3.320

6.  High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health.

Authors:  Axel C Carlsson; Per Wändell; Urban Ösby; Ramin Zarrinkoub; Björn Wettermark; Gunnar Ljunggren
Journal:  BMC Public Health       Date:  2013-07-18       Impact factor: 3.295
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.